Clinical trial
Multicentre, Prospective, Non-interventional Study Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes
NCT06100042 is registered in ClinicalTrials.gov with Chiesi Italia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentre, Prospective, Non-interventional Study Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes
- Lead sponsor
- Chiesi Italia
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 24, 2024
- Completion date
- June 12, 2026
- Enrollment
- 233 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.